Literature DB >> 9525987

Excess corticotropin releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice.

H L Burrows1, M Nakajima, J S Lesh, K A Goosens, L C Samuelson, A Inui, S A Camper, A F Seasholtz.   

Abstract

Corticotropin-releasing hormone (CRH) is the primary hypothalamic releasing factor that mediates the mammalian stress response. The CRH-binding protein (CRH-BP) is secreted from corticotropes, the pituitary CRH target cells, suggesting that the CRH-BP may modulate hypothalamic-pituitary-adrenal (HPA) axis activity by preventing CRH receptor stimulation. Transgenic mice were generated that constitutively express elevated levels of CRH-BP in the anterior pituitary gland. RNA and protein analyses confirmed the elevation of pituitary CRH-BP. Basal plasma concentrations of corticosterone and adrenocorticotropin hormone (ACTH) are unchanged, and a normal pattern of increased corticosterone and ACTH was observed after restraint stress. However, CRH and vasopressin (AVP) mRNA levels in the transgenic mice are increased by 82 and 35%, respectively, to compensate for the excess CRH-BP, consistent with the idea that CRH-BP levels are important for homeostasis. The transgenic mice exhibit increased activity in standard behavioral tests, and an altered circadian pattern of food intake which may be due to transgene expression in the brain. Alterations in CRH and AVP in response to elevated pituitary CRH-BP clearly demonstrate that regulation of CRH-BP is important in the function of the HPA axis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525987      PMCID: PMC508722          DOI: 10.1172/JCI1963

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  A specific carrier substance for human corticotrophin releasing factor in late gestational maternal plasma which could mask the ACTH-releasing activity.

Authors:  E A Linton; C D Wolfe; D P Behan; P J Lowry
Journal:  Clin Endocrinol (Oxf)       Date:  1988-03       Impact factor: 3.478

2.  Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice.

Authors:  L J Muglia; L Jacobson; S C Weninger; C E Luedke; D S Bae; K H Jeong; J A Majzoub
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 3.  The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.

Authors:  R M Sapolsky; L C Krey; B S McEwen
Journal:  Endocr Rev       Date:  1986-08       Impact factor: 19.871

4.  The use of a plus-maze to measure anxiety in the mouse.

Authors:  R G Lister
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.

Authors:  J P Herman; S J Wiegand; S J Watson
Journal:  Endocrinology       Date:  1990-11       Impact factor: 4.736

6.  Characterization of corticotropin-releasing hormone binding protein in human plasma by chemical cross-linking and its binding during pregnancy.

Authors:  T Suda; M Iwashita; F Tozawa; T Ushiyama; N Tomori; T Sumitomo; Y Nakagami; H Demura; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1988-12       Impact factor: 5.958

7.  Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin.

Authors:  G E Gillies; E A Linton; P J Lowry
Journal:  Nature       Date:  1982-09-23       Impact factor: 49.962

8.  Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats.

Authors:  W S Young; E Mezey; R E Siegel
Journal:  Neurosci Lett       Date:  1986-10-08       Impact factor: 3.046

9.  Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy.

Authors:  A Sasaki; A S Liotta; M M Luckey; A N Margioris; T Suda; D T Krieger
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

10.  Effects of lateral and medial septal lesions on various activity and reactivity measures in rats.

Authors:  E H Lee; Y P Lin; T H Yin
Journal:  Physiol Behav       Date:  1988
View more
  20 in total

Review 1.  Lessons learned from gene targeting and transgenesis for adrenal physiology and disease.

Authors:  A Böttner; S R Bornstein
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Conversion of short-term to long-term memory in the novel object recognition paradigm.

Authors:  Shannon J Moore; Kaivalya Deshpande; Gwen S Stinnett; Audrey F Seasholtz; Geoffrey G Murphy
Journal:  Neurobiol Learn Mem       Date:  2013-07-05       Impact factor: 2.877

3.  Protein-disulfide isomerase regulates the thyroid hormone receptor-mediated gene expression via redox factor-1 through thiol reduction-oxidation.

Authors:  Shoko Hashimoto; Susumu Imaoka
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

Review 4.  Genetic animal models of anxiety.

Authors:  Deborah A Finn; Mark T Rutledge-Gorman; John C Crabbe
Journal:  Neurogenetics       Date:  2003-03-29       Impact factor: 2.660

5.  Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice.

Authors:  I J Karolyi; H L Burrows; T M Ramesh; M Nakajima; J S Lesh; E Seong; S A Camper; A F Seasholtz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

6.  Environmental stressors influence limited-access ethanol consumption by C57BL/6J mice in a sex-dependent manner.

Authors:  Debra K Cozzoli; Michelle A Tanchuck-Nipper; Moriah N Kaufman; Chloe B Horowitz; Deborah A Finn
Journal:  Alcohol       Date:  2014-10-18       Impact factor: 2.405

7.  Pituitary CRH-binding protein and stress in female mice.

Authors:  Gwen S Stinnett; Nicole J Westphal; Audrey F Seasholtz
Journal:  Physiol Behav       Date:  2015-02-27

Review 8.  Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans.

Authors:  Kyle D Ketchesin; Gwen S Stinnett; Audrey F Seasholtz
Journal:  Stress       Date:  2017-05-18       Impact factor: 3.493

9.  Deletion of corticotropin-releasing factor binding protein selectively impairs maternal, but not intermale aggression.

Authors:  S C Gammie; A F Seasholtz; S A Stevenson
Journal:  Neuroscience       Date:  2008-09-27       Impact factor: 3.590

10.  Gene regulation system of vasopressin and corticotropin-releasing hormone.

Authors:  Masanori Yoshida
Journal:  Gene Regul Syst Bio       Date:  2008-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.